Skip to main content
. 2017 Feb 1;39(3):654–662. doi: 10.3892/ijmm.2017.2872

Figure 5.

Figure 5

Representative images of alkaline phosphatase (ALP) staining of umbilical cord-derived mesenchymal stromal cells (UC-MSCs) and bone marrow-derived mesenchymal stromal cells (BM-MSCs) following treatment with bone morphogenetic protein-2 (BMP-2) for 3, 7, 14, 21 and 28 days. OstDiff, osteogenic differentiation medium; OstDiff + BMP-2, osteogenic differentiation medium supplemented with BMP-2. Scale bar, 100 µm.